Davis Polk advised Citigroup Global Markets Inc. as dealer manager for a cash tender offer by Stanley Black & Decker, Inc. to purchase any and all of its outstanding 6.15% notes due 2013 and any and all of the 8.95% notes due 2014 and the 4.75% notes due 2014 issued by The Black & Decker Corporation, a wholly owned subsidiary of Stanley Black & Decker, Inc. Stanley Black & Decker purchased approximately $376.6 million aggregate principal amount of notes under the tender offer.

More >>

Davis Polk advised Archway Marketing Services and its majority shareholder Tailwind Capital on the sale of Archway to Investcorp for approximately $300 million.

More >>

Davis Polk advised Credit Suisse Securities (USA) LLC as representative of the several underwriters of a $46 million SEC-registered follow-on offering of 7,076,922 shares of common stock of XenoPort, Inc. Xenoport’s common stock is traded on the Nasdaq Global Select Market under the symbol “XNPT.”

More >>

Paul Hastings LLP, a leading global law firm, announced today that the firm represented William Macklowe Co. in the sale of two office buildings. William Macklowe has sold majority interests in 400 Madison to ASB Real Estate for $148 million and 610 Broadway to LaSalle Investment Management for $116 million. William Macklowe Co. retains 10% stakes in each property.

More >>

Citing a need to expand services to the pharmaceutical and medical device industries, Polsinelli Shughart welcomes three highly experienced intellectual property shareholders in New York. Tedd W. Van Buskirk, Dr. Pamela Fekete, and Dillon Kim bring more than 35 years combined experience in patent and trademark matters. The trio, who practiced together previously, focuses predominantly on patent litigation arising under the Hatch-Waxman Act and related regulatory, antitrust, and ANDA counseling work. Their clients include pharmaceutical, medical device, biotech, and other life sciences companies.

More >>